Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Yoshihide Takeshita"'
Autor:
Yoshihide Takeshita, Narimasa Katsuta
Publikováno v:
PCN Reports, Vol 3, Iss 3, Pp n/a-n/a (2024)
Abstract Since the onset of the coronavirus disease 2019 (COVID‐19) pandemic in 2020, specialized COVID‐19 wards have been established in general hospitals across Japan. Juntendo Hospital also established a dedicated COVID‐19 ward; however, man
Externí odkaz:
https://doaj.org/article/72a9e5535d254a40ab7fed4ccfffd98c
Autor:
Yusuke Miyazawa, Narimasa Katsuta, Tamaki Nara, Shuko Nojiri, Toshio Naito, Makoto Hiki, Masako Ichikawa, Yoshihide Takeshita, Tadafumi Kato, Manabu Okumura, Morikuni Tobita
Publikováno v:
PLoS ONE, Vol 19, Iss 1, p e0296760 (2024)
COVID-19 has a range of complications, from no symptoms to severe pneumonia. It can also affect multiple organs including the nervous system. COVID-19 affects the brain, leading to neurological symptoms such as delirium. Delirium, a sudden change in
Externí odkaz:
https://doaj.org/article/8d38e6de8b8941b187e1766e62a2993d
Autor:
Narimasa Katsuta, Keitaro Takahashi, Yui Kurosawa, Akane Yoshikawa, Yoshihide Takeshita, Yoshihiro Uchida, Seita Yasuda, Chihiro Kakiuchi, Masanobu Ito, Tadafumi Kato
Publikováno v:
Sleep Medicine: X, Vol 5, Iss , Pp 100070- (2023)
Aim: To investigate the real-world effectiveness and safety of lemborexan for treating comorbid insomnia associated with other psychiatric disorders, and whether lemborexant helps reduce the dose of benzodiazepines (BZs). Methods: This retrospective
Externí odkaz:
https://doaj.org/article/035d9e56018b469081d41b61f9c762a6
Autor:
Ayako Suzuki, Nobuto Shibata, Koji Kasanuki, Tomoyuki Nagata, Shunichiro Shinagawa, Nobuyuki Kobayashi, Tohru Ohnuma, Yoshihide Takeshita, Eri Kawai, Toshiki Takayama, Kenya Nishioka, Yumiko Motoi, Nobutaka Hattori, Kazuhiko Nakayama, Hisashi Yamada, Heii Arai
Publikováno v:
Dementia and Geriatric Cognitive Disorders Extra, Vol 6, Iss 1, Pp 90-97 (2016)
Background/Aims: Mutations in the presenilin 2 (PSEN2) gene cause familial Alzheimer's disease (AD). Common polymorphisms affect gene activity and increase the risk of AD. Nonsynonymous polymorphisms in the PSEN2 gene showed Lewy body dementia (LBD)
Externí odkaz:
https://doaj.org/article/6442245d32674aca9f0f80089e02ac8a
Autor:
Nobuto Shibata, Yoshihide Takeshita, Tohru Ohnuma, Toshiki Takayama, Moto Nishiguchi, Ayako Suzuki, Heii Arai, Koichi Miyakawa
Publikováno v:
Juntendo Medical Journal. 64:216-222
Autor:
Toshiki Takayama, Heii Arai, Nobuto Shibata, Kenya Nishioka, Tomoyuki Nagata, Hisashi Yamada, Nobutaka Hattori, Yoshihide Takeshita, Koji Kasanuki, Kazuhiko Nakayama, Ayako Suzuki, Shunichiro Shinagawa, Tohru Ohnuma, Yumiko Motoi, Eri Kawai, Nobuyuki Kobayashi
Publikováno v:
International Journal of Geriatric Psychiatry. 32:1241-1246
Background/Aims Interaction of receptor for advanced glycation end products (RAGE) with amyloid-β increases amplification of oxidative stress and plays pathological roles in Alzheimer's disease (AD). Oxidative stress leads to α-synuclein aggregatio
Autor:
Kenya Nishioka, Nobuto Shibata, Nobutaka Hattori, Yumiko Motoi, Yoshihide Takeshita, Shunichiro Shinagawa, Toshiki Takayama, Ayako Suzuki, Koji Kasanuki, Tohru Ohnuma, Heii Arai, Nobuyuki Kobayashi, Kazuhiko Nakayama, Eri Kawai, Tomoyuki Nagata, Hisashi Yamada
Publikováno v:
Dementia and Geriatric Cognitive Disorders EXTRA
Dementia and Geriatric Cognitive Disorders Extra, Vol 6, Iss 1, Pp 90-97 (2016)
Dementia and Geriatric Cognitive Disorders Extra, Vol 6, Iss 1, Pp 90-97 (2016)
Background/Aims: Mutations in the presenilin 2 (PSEN2) gene cause familial Alzheimer's disease (AD). Common polymorphisms affect gene activity and increase the risk of AD. Nonsynonymous polymorphisms in the PSEN2 gene showed Lewy body dementia (LBD)
Autor:
Yoshihide, Takeshita, Nobuto, Shibata, Koji, Kasanuki, Tomoyuki, Nagata, Shunichiro, Shinagawa, Nobuyuki, Kobayashi, Tohru, Ohnuma, Ayako, Suzuki, Eri, Kawai, Toshiki, Takayama, Kenya, Nishioka, Yumiko, Motoi, Nobutaka, Hattori, Kazuhiko, Nakayama, Hisashi, Yamada, Heii, Arai
Publikováno v:
International journal of geriatric psychiatry. 32(12)
Interaction of receptor for advanced glycation end products (RAGE) with amyloid-β increases amplification of oxidative stress and plays pathological roles in Alzheimer's disease (AD). Oxidative stress leads to α-synuclein aggregation and is also a